Literature DB >> 14506034

Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections.

Patricia Komp Lindgren1, Asa Karlsson, Diarmaid Hughes.   

Abstract

Escherichia coli strains from patients with uncomplicated urinary tract infections were examined by DNA sequencing for fluoroquinolone resistance-associated mutations in six genes: gyrA, gyrB, parC, parE, marOR, and acrR. The 54 strains analyzed had a susceptibility range distributed across 15 dilutions of the fluoroquinolone MICs. There was a correlation between the fluoroquinolone MIC and the number of resistance mutations that a strain carried, with resistant strains having mutations in two to five of these genes. Most resistant strains carried two mutations in gyrA and one mutation in parC. In addition, many resistant strains had mutations in parE, marOR, and/or acrR. No (resistance) mutation was found in gyrB. Thus, the evolution of fluoroquinolone resistance involves the accumulation of multiple mutations in several genes. The spontaneous mutation rate in these clinical strains varied by 2 orders of magnitude. A high mutation rate correlated strongly with a clinical resistance phenotype. This correlation suggests that an increased general mutation rate may play a significant role in the development of high-level resistance to fluoroquinolones by increasing the rate of accumulation of rare new mutations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14506034      PMCID: PMC201150          DOI: 10.1128/AAC.47.10.3222-3232.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  65 in total

1.  Mutation in the DNA gyrase A Gene of Escherichia coli that expands the quinolone resistance-determining region.

Authors:  S M Friedman; T Lu; K Drlica
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

2.  Mutator bacteria as a risk factor in treatment of infectious diseases.

Authors:  Antoine Giraud; Ivan Matic; Miroslav Radman; Michel Fons; François Taddei
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

3.  The complete genome sequence of Escherichia coli K-12.

Authors:  F R Blattner; G Plunkett; C A Bloch; N T Perna; V Burland; M Riley; J Collado-Vides; J D Glasner; C K Rode; G F Mayhew; J Gregor; N W Davis; H A Kirkpatrick; M A Goeden; D J Rose; B Mau; Y Shao
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

4.  Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations.

Authors:  H Wang; J L Dzink-Fox; M Chen; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

5.  A close correlation between improvement of organic solvent tolerance levels and alteration of resistance toward low levels of multiple antibiotics in Escherichia coli.

Authors:  R Aono; M Kobayashi; H Nakajima; H Kobayashi
Journal:  Biosci Biotechnol Biochem       Date:  1995-02       Impact factor: 2.043

6.  Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance.

Authors:  D J Jin; C A Gross
Journal:  J Mol Biol       Date:  1988-07-05       Impact factor: 5.469

7.  Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli.

Authors:  M Oethinger; W V Kern; J D Goldman; S B Levy
Journal:  J Antimicrob Chemother       Date:  1998-01       Impact factor: 5.790

8.  Identification for mar mutants among quinolone-resistant clinical isolates of Escherichia coli.

Authors:  K Maneewannakul; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

9.  An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project.

Authors:  G Kahlmeter
Journal:  J Antimicrob Chemother       Date:  2003-01       Impact factor: 5.790

10.  Genetics and regulation of outer membrane protein expression by quinolone resistance loci nfxB, nfxC, and cfxB.

Authors:  D C Hooper; J S Wolfson; M A Bozza; E Y Ng
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

View more
  116 in total

1.  Polymorphic mutation frequencies in Escherichia coli: emergence of weak mutators in clinical isolates.

Authors:  María-Rosario Baquero; Annika I Nilsson; María del Carmen Turrientes; Dorthe Sandvang; Juan Carlos Galán; Jose Luís Martínez; Niels Frimodt-Møller; Fernando Baquero; Dan I Andersson
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

2.  De Novo Characterization of Genes That Contribute to High-Level Ciprofloxacin Resistance in Escherichia coli.

Authors:  Thu Tran; Qinghong Ran; Lev Ostrer; Arkady Khodursky
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

3.  Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility.

Authors:  Oren Zimhony; Inna Chmelnitsky; Rita Bardenstein; Sorel Goland; Orly Hammer Muntz; Shiri Navon Venezia; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

4.  Pharmacodynamic model to describe the concentration-dependent selection of cefotaxime-resistant Escherichia coli.

Authors:  Sara K Olofsson; Patricia Geli; Dan I Andersson; Otto Cars
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

5.  Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus.

Authors:  Hiep N'Guyen Trong; Anne-Laure Prunier; Roland Leclercq
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

6.  Induction and inhibition of ciprofloxacin resistance-conferring mutations in hypermutator bacteria.

Authors:  Ryan T Cirz; Floyd E Romesberg
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

7.  Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.

Authors:  Hervé Nicoloff; Vincent Perreten; Stuart B Levy
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

8.  Weak mutators can drive the evolution of fluoroquinolone resistance in Escherichia coli.

Authors:  Hanna Orlén; Diarmaid Hughes
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

9.  Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe.

Authors:  Hedi Mammeri; Marc Van De Loo; Laurent Poirel; Luis Martinez-Martinez; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

10.  Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital.

Authors:  Véronique Leflon-Guibout; Cécile Jurand; Stéphane Bonacorsi; Florence Espinasse; Marie Claude Guelfi; Françoise Duportail; Beate Heym; Edouard Bingen; Marie-Hélène Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.